Literature DB >> 25639735

The tumour stromal features are associated with resistance to 5-FU-based chemoradiotherapy and a poor prognosis in patients with oral squamous cell carcinoma.

Yuichiro Matsuoka1, Ryoji Yoshida, Hideki Nakayama, Masashi Nagata, Akiyuki Hirosue, Takuya Tanaka, Kenta Kawahara, Yoshihiro Nakagawa, Jyunki Sakata, Hidetaka Arita, Akimitsu Hiraki, Masanori Shinohara.   

Abstract

It has been increasingly recognized that the tumour microenvironment is a critical factor involved in cancer progression. However, little is known about the clinical value of the stromal features in oral squamous cell carcinoma (OSCC). The purpose of this study was to determine the clinical significance of cancer-associated fibroblasts (CAFs) and tumour-associated macrophages (TAMs) in OSCC. OSCC specimens were obtained from 60 patients who underwent surgery following 5-fluorouracil-based chemoradiotherapy. Paraffin-embedded sections obtained from biopsy specimens were immunohistochemically analysed. The associations among CAFs, TAMs and various clinicopathological features were examined, and the effects of CAFs and TAMs on the prognosis were evaluated. In the group with a high level of CAFs, the incidence of advanced pT- and pN-stage cases was significantly higher than that in the group with the low level. A high TAMs tumour expression was significantly correlated with a poor response to preoperative chemoradiotherapy. A Kaplan-Meier analysis revealed that higher numbers of CAFs and TAMs were significantly correlated with a poor prognosis. These findings suggest that TAMs are a potential biomarker for predicting the clinical response to 5-FU-based chemoradiotherapy, and the expression status of the CAFs and TAMs may be useful for making treatment decisions to improve the survival of OSCC patients.
© 2014 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Oral squamous cell carcinoma (OSCC); cancer-associated fibroblasts (CAFs); prognosis; resistance; tumour-associated macrophages (TAMs)

Mesh:

Substances:

Year:  2014        PMID: 25639735     DOI: 10.1111/apm.12344

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  11 in total

Review 1.  Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects.

Authors:  Yuval Shaked
Journal:  Nat Rev Clin Oncol       Date:  2016-04-26       Impact factor: 66.675

2.  IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma.

Authors:  Yuichiro Matsuoka; Hideki Nakayama; Ryoji Yoshida; Akiyuki Hirosue; Masashi Nagata; Takuya Tanaka; Kenta Kawahara; Junki Sakata; Hidetaka Arita; Hikaru Nakashima; Satoru Shinriki; Daiki Fukuma; Hidenao Ogi; Akimitsu Hiraki; Masanori Shinohara; Ryo Toya; Ryuji Murakami
Journal:  Br J Cancer       Date:  2016-10-13       Impact factor: 7.640

Review 3.  Translational Significance for Tumor Metastasis of Tumor-Associated Macrophages and Epithelial-Mesenchymal Transition.

Authors:  Wenzhe Song; Roberta Mazzieri; Tao Yang; Glenda C Gobe
Journal:  Front Immunol       Date:  2017-09-13       Impact factor: 7.561

4.  Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia.

Authors:  Junki Sakata; Ryoji Yoshida; Yuichiro Matsuoka; Masashi Nagata; Akiyuki Hirosue; Kenta Kawahara; Takuya Nakamura; Masafumi Nakamoto; Masatoshi Hirayama; Nozomu Takahashi; Hikaru Nakashima; Hidetaka Arita; Hidenao Ogi; Akimitsu Hiraki; Masanori Shinohara; Hideki Nakayama
Journal:  Cancer Med       Date:  2017-03-03       Impact factor: 4.452

Review 5.  Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities.

Authors:  Zhanhuai Wang; Yang Tang; Yinuo Tan; Qichun Wei; Wei Yu
Journal:  Cell Commun Signal       Date:  2019-05-17       Impact factor: 5.712

6.  Tissue-infiltrating immune cells as prognostic markers in oral squamous cell carcinoma: a systematic review and meta-analysis.

Authors:  Elin Hadler-Olsen; Anna Maria Wirsing
Journal:  Br J Cancer       Date:  2019-02-27       Impact factor: 7.640

7.  Prognostic Significance of Tumor-Associated Macrophage Content in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis.

Authors:  Ayan Tyagi Kumar; Alexander Knops; Brian Swendseid; Ubaldo Martinez-Outschoom; Larry Harshyne; Nancy Philp; Ulrich Rodeck; Adam Luginbuhl; David Cognetti; Jennifer Johnson; Joseph Curry
Journal:  Front Oncol       Date:  2019-07-23       Impact factor: 6.244

8.  RACK1 promotes cancer progression by increasing the M2/M1 macrophage ratio via the NF-κB pathway in oral squamous cell carcinoma.

Authors:  Hongxia Dan; Sai Liu; Jiajia Liu; Dongjuan Liu; Fengying Yin; Zihao Wei; Jiongke Wang; Yu Zhou; Lu Jiang; Ning Ji; Xin Zeng; Jing Li; Qianming Chen
Journal:  Mol Oncol       Date:  2020-02-20       Impact factor: 6.603

Review 9.  The Role of Macrophages in Oral Squamous Cell Carcinoma.

Authors:  Eleni Marina Kalogirou; Konstantinos I Tosios; Panagiotis F Christopoulos
Journal:  Front Oncol       Date:  2021-03-18       Impact factor: 6.244

Review 10.  Tumor microenvironment and radioresistance.

Authors:  Tatsuya Suwa; Minoru Kobayashi; Jin-Min Nam; Hiroshi Harada
Journal:  Exp Mol Med       Date:  2021-06-16       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.